Aravive, Inc.
ARAVDelisted Jan 29, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001513818
Aravive, Inc. was delisted on Jan 29, 2024; its insiders filed their last Form 4 on Apr 11, 2023; 30 institutions reported holding it in 13F filings for Q4 2023, worth $825.5K in total; no superinvestor held it.
13F holders, Q1 2022
Institutional positions in Aravive, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 37
- +1 vs. Q4 2021
- Shares held
- 5.24M
- +676.8K (+14.8%) vs. Q4 2021
- Total value
- $10.1M
- +$117.9K (+1.2%) vs. Q4 2021
- New holders
- 5
- 6 more added
- Sold out
- 4
- 16 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ARAV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $373 |
| Q1 2026 | 1 | $373 |
| Q4 2025 | 2 | $373 |
| Q3 2025 | 1 | $373 |
| Q2 2025 | 1 | $373 |
| Q1 2025 | 1 | $373 |
| Q4 2024 | 2 | $373 |
| Q3 2024 | 1 | $373 |
| Q2 2024 | 1 | $373 |
| Q1 2024 | 3 | $69.4K |
| Q4 2023 | 30 | $825.5K |
| Q3 2023 | 33 | $786.9K |
| Q2 2023 | 35 | $21.5M |
| Q1 2023 | 36 | $36.9M |
| Q4 2022 | 32 | $20.1M |
| Q3 2022 | 28 | $3.24M |
| Q2 2022 | 36 | $5.47M |
| Q1 2022 | 37 | $10.1M |
| Q4 2021 | 36 | $9.99M |
| Q3 2021 | 45 | $17.7M |
| Q2 2021 | 49 | $35.3M |
| Q1 2021 | 59 | $42.8M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Aravive, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bank of America Corp | 66 | $0 | 0.00% | −5,234−98.8% | Reduced |
| JPMorgan Chase & Co | 88 | $0 | 0.00% | +69+363.2% | Added |
| Worth Asset Management, LLC | 120 | $0 | 0.00% | +120 | New |
| BNP Paribas Arbitrage, SA | 346 | $668 | 0.00% | −2−0.6% | Reduced |
| Federated Hermes, Inc. | 441 | $1.00K | 0.00% | −33,931−98.7% | Reduced |
| Tower Research Capital LLC (TRC) | 1,266 | $2.00K | 0.00% | −3,642−74.2% | Reduced |
| Newbridge Financial Services Group, Inc. | 841 | $2.00K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 1,479 | $3.00K | 0.00% | +1,479 | New |
| Massmutual Trust Co FSB | 9,300 | $18.0K | 0.00% | 00.0% | Unchanged |
| Schonfeld Strategic Advisors LLC | 11,400 | $22.0K | 0.00% | 00.0% | Unchanged |
| Geneos Wealth Management Inc. | 12,810 | $24.0K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 15,203 | $29.0K | 0.00% | +12,173+401.7% | Added |
| ACT Capital Management, LLC | 17,500 | $34.0K | 0.04% | +7,500+75.0% | Added |
| Bradley & Co. Private Wealth Management, LLC | 18,339 | $35.0K | 0.03% | +18,339 | New |
| Wells Fargo & Company | 22,569 | $43.0K | 0.00% | +2,501+12.5% | Added |
| Verition Fund Management LLC | 25,000 | $48.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 31,987 | $62.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 32,874 | $63.0K | 0.00% | −522−1.6% | Reduced |
| Franklin Resources Inc | 37,800 | $73.0K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 41,000 | $79.0K | 0.00% | −9,695−19.1% | Reduced |
| Two Sigma Investments, LP | 50,928 | $98.0K | 0.00% | −48,532−48.8% | Reduced |
| Susquehanna International Group, LLP | 55,865 | $108.0K | 0.00% | +36,209+184.2% | Added |
| Bridgeway Capital Management, LLC | 57,625 | $111.0K | 0.00% | −10,000−14.8% | Reduced |
| Bank of New York Mellon Corp | 58,818 | $113.0K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 60,938 | $118.0K | 0.00% | −48,453−44.3% | Reduced |
| Morgan Stanley | 66,549 | $128.0K | 0.00% | −1,716−2.5% | Reduced |
| Bluefin Capital Management, LLC | 71,537 | $138.0K | 0.02% | +71,537 | New |
| Dimensional Fund Advisors LP | 92,109 | $178.0K | 0.00% | −320−0.3% | Reduced |
| Two Sigma Advisers, LP | 96,848 | $187.0K | 0.00% | −55,200−36.3% | Reduced |
| Acadian Asset Management LLC | 116,353 | $223.0K | 0.00% | +7,184+6.6% | Added |
| Geode Capital Management, LLC | 129,118 | $249.0K | 0.00% | −20.0% | Reduced |
| BlackRock Inc. | 172,703 | $333.0K | 0.00% | −1,872−1.1% | Reduced |
| Renaissance Technologies LLC | 277,829 | $536.0K | 0.00% | −64,500−18.8% | Reduced |
| Vanguard Group Inc | 457,220 | $882.0K | 0.00% | −63,023−12.1% | Reduced |
| Armistice Capital, LLC | 934,975 | $1.80M | 0.05% | +934,975 | New |
| New Leaf Venture Partners, L.L.C. | 946,423 | $1.83M | 0.90% | 00.0% | Unchanged |
| Artal Group S.A. | 1,311,291 | $2.53M | 0.11% | 00.0% | Unchanged |
| Walleye Capital LLC | 0 | $0 | 0.00% | −36,987−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −18,420−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −12,551−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −650−100.0% | Sold out |